Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model

British Journal of Cancer

Volumn 74, Issue 8, 1996, Pages 1194-1198

  Goff, B A ^a,b   Blake, J ^a   Bamberg, M P ^a   Hasan, T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Chlorin; Immunoconjugate; OC125; Ovarian photodynamic therapy; Photoimmunotherapy

Indexed keywords

ANTIBODY CONJUGATE; CHLORIN E6 MONOETHYLENEDIAMINE MONOAMIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OC 125; PHOTOSENSITIZING AGENT; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTINEOPLASTIC ACTIVITY; ARGON LASER; ARTICLE; CANCER MODEL; CANCER SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TARGETING; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OVARY CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0029851175     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.516     Document Type: Article

References (30)

1. BAST JR RC, FEENEY M. LAZSARUS H, NADLER LM, COLVIN RB AND KNAPP RC. (1981). Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest., 68, 1331 - 1337.
2. BAST JR RC, KLUG TL, ST. JOHN E, JENISON E, NILOFF JM, LAZARUS H, BERKOWITZ RS, LEAVITT T, GRIFFITHS CT, PARKER L, ZURAWSKIVR JR AND KNAPP RCA. (1983). A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Eng. J. Med., 309, 883-887.
3. CHATAL JF, SACCAVINI JC, GESTIN JF, THEDREZ P, CURET C, KREMER M, GUERREAU D, NOLIBE D, FUMOLEAU P AND GUILLARD Y. (1989). Biodistribution of indium-111-labeled OC125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. Cancer Res., 49, 3087-3094.
4. DELANEY TF, SINDELAR WF, TOCHNER Z, SMITH PD, FRIAUF WS, THOMAS G, DACHOWSKI L, COLE JW, STEINBERG SM AND GLATSTEIN E. (1993). Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Radiat. Oncol. Biol. Phys., 25, 445-447.
5. DOUGHERTY TL. (1987). Photosensitizers: therapy and detection of malignant tumors. Photochem. Photobiol., 45, 879-889.
6. FERRARIO A AND GOMER CT. (1990). Systemic toxicity in mice induced by localized porphyrin photodynamic therapy. Cancer Res., 50, 539-543.
7. GOFF BA, BAMBERG M AND HASAN T. (1991). Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res., 51, 339-344.
8. GOFF BA, BAMBERG M AND HASAN T. (1992). Experimental photodynamic treatment of ovarian carcinoma cells with immunoconjugates. Antibody Immunoconj. Radiopharm., 5, 191-199.
9. GOFF BA, HERMANTO U, RUMBAUGH J, BLAKE J, BAMBERG M AND HASAN T. (1994). Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br. J. Cancer, 70, 474-480.
10. GOMER CJ. (1991). Prelinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem. Photobiol., 54, 1093-1107.
11. HAMILTON TC, YOUNG RC, MCKOY WM, GROTZINGER KR, GREEN JA, CHU EW, WHANG-PENG J, ROGAN AM, GREEN WR AND OZOLS RF. (1983). Characterization of a human ovarian carcinoma cell line (NIH:OVCAR3) with androgen and estrogen receptors. Cancer Res., 43, 5379-5389.
12. HAMILTON TC, YOUNG RC, LOUIS KG et at. (1984). Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. Cancer Res., 44, 5286-5290.
13. HASAN T. (1992). Photosensitizer delivery mediated by macromolecular carrier systems. In Photodynamic Therapy: Basic Principles and Clinical Applications Henderson B and Dougherty T (eds). pp. 187-200. Marcel Dekker: New York.
14. HASAN T AND PARRISH HA. (1996). Photodynamic therapy of cancer. In Cancer Medicine. Fourth Edition. Holland JF (ed.) Williams & Wilkins: Baltimore (in press).
15. HASAN T, LIN A, YARMUSH D, OSEROFF A AND YARMUSH M.(1989). Monoclonal antibody-chromophore conjugates as selective phototoxins. J. Controlled Release, 10, 107-117.
16. HENDERSON BW AND DOUGHERTY TJ. (1992). How does photodynamic therapy work? Photochem. Photobiol., 55, 145-157.
17. LILGE L, DABROWSKI W, HOLDSWORTH D, BLAKE J, KATO D, WILSON B AND HASAN T. (1994). Light delivery and dosimetry for photodynamic therapy in an ovarian-cancer mouse model. Spie Proc., 2133, 150-161.
18. MEW D, WAT CK, TOWERS GH AND LEVY JG. (1983). Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J. Immunol., 130, 1473-1477.
19. MOLPUS KL, KATO D, LILGE K, HAMBLIN MR, KOELLIKER D, BAMBERG M AND HASAN T. (1996). Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Rex., 56, 1075-1082.
20. MOSMANN T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods, 65, 55-63.
21. MUTO MG, FINKLER NJ, KASSIS AI, LEPISTO EM AND KNAPP RC. (1990). Human anti-murinc antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC125. Gynecol. Oncol., 38, 244-248.
22. MUTO MG, FINKLER NJ, KASSIS AI, HOWES AE, ANDERSON LL, LAU CC, ZURAWSKI VR, WEADOCK K, TUMEH SS, LAVIN P AND KAPP RC. (1992). Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC128. Gynecol. Oncol., 45, 265-272.
23. PASS HI. (1993). Photodynamic therapy in oncology: mechanisms and clinical use. J. Nutl Cancer Inst., 85, 443-456.
24. PETERSON CM, REED R, JOLLES CJ, JONES KP, STRAIGHT AND POULSON AM. (1992). Photodynamic therapy of human ovarian epithelial carcinoma, OVCAR-3, heterotransplanted in the nude mouse. Am. J. Obstet, Gynecol., 167, 1852-1855.
25. SCHMIDT S, WAGNER U, SCHULTKS B, OEHR P, DECLEER W, ERTMER W, LUBASCHOWSKI H, BIERSACK HJ AND KREBS D. (1992). Photodynamic laser therapy with antibody-hound dyes. A new procedure in therapy of gynecologic malignancies (in German). Fortschr. Med., 110, 298-301.
26. SINDELAR WF, DELANEY TF, TOCHNER Z, THOMAS GF, DACHOWSKI LJ, SMITH PD, FRIAUF WS, COLE JW AND GLATSTEIN E. (1991). Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Arch. Surg., 126, 318-324.
27. STAR WM, WILSON BC AND PATTERSON M. (1992). Light delivery and optical dosimetry in photodynamic therapy of solid tumors. In Photodynamic Therapy: Basic Principles and Clinical Applications. Henderson B and Dougherty TJ (eds), pp. 187-200. Marcel Dekker:
28. TAKITA H, MANG TS, LOEWEN GM, ANTKOWIAK JG, RAGHAVAN D, GRAJEK JR AND DOUGHERTY TJ. (1994). Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann. Thorac. Surg., 58, 995-998.
29. TOCHNER Z, MITCHELL JB, HARRINGTON FS, SMITH P, RUSSO DT AND RUSSO A. (1985). Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light. Cancer Res., 45, 2983-2987.
30. TOCHNER Z, MITCHELL JB, SMITH P, GLATSTEIN E, RUSSO DT AND ROSSO A. (1986). Photodynamic therapy of aseites tumor within the peritoneal cavity. Br. J. Cancer. 53, 733-736.